• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Archimedes Pharma

Anonymous board for Archimedes Pharma
Replies
28
Views
27K
anonymous
Replies
0
Views
2K
anonymous
Replies
12
Views
8K
Anonymous
Replies
51
Views
19K
Anonymous
Replies
2
Views
4K
Anonymous
Replies
3
Views
4K
Anonymous
Replies
21
Views
10K
Anonymous
Replies
9
Views
7K
Anonymous